4Tissue Strengthens Its Capacity by Bringing Onboard Dr. Vesna Kostanjevecki as Head of Clinical and Regulatory Affairs

We are thrilled to announce that Dr. Vesna Kostanjevecki has joined 4Tissue as our new Head of Clinical and Regulatory Affairs. As we prepare for the first clinical studies of our innovative hydrogel technology, Dr. Kostanjevecki's appointment is a key step in strengthening our capacity to successfully navigate the regulatory and quality control requirements.

Her extensive expertise in clinical and regulatory affairs will be instrumental as we move forward in this critical phase. Dr. Kostanjevecki previously served as the Vice President of Clinical & Regulatory Affairs at miDiagnostics and held key roles in R&D at imec, Innogenetics and Fujirebio Europe NV where she spent nearly two decades as R&D Director.

With a PhD in Biochemistry from the University of Gent and a Master of Science in Engineering specializing in Biochemistry and Molecular Biology from the University of Zagreb, Dr. Kostanjevecki's experience will be vital in guiding 4Tissue as we advance our minimally invasive injectable hydrogel solution that promotes natural tissue regeneration.